Works matching IS 03065251 AND DT 1989 AND VI 28 AND IP 2
1
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 175, doi. 10.1111/j.1365-2125.1989.tb05412.x
- Viani, A.;
- Carrai, M.;
- Pacifici, GM
- Article
2
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 137, doi. 10.1111/j.1365-2125.1989.tb05405.x
- Begg, EJ;
- Atkinson, HC;
- Jeffery, GM;
- Taylor, NW
- Article
3
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 193, doi. 10.1111/j.1365-2125.1989.tb05416.x
- Meyer, FA;
- Yaron, I.;
- Mashiah, V.;
- Yaron, M.
- Article
4
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 161, doi. 10.1111/j.1365-2125.1989.tb05409.x
- Atiba, JO;
- Blaschke, TF;
- Wilkinson, GR
- Article
5
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 171, doi. 10.1111/j.1365-2125.1989.tb05411.x
- Article
6
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 211P, doi. 10.1111/j.1365-2125.1989.tb05422.x
- Article
7
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 125, doi. 10.1111/j.1365-2125.1989.tb05404.x
- Evans, JM;
- Barnes, NC;
- Zakrzewski, JT;
- Sciberras, DG;
- Stahl, EG;
- Piper, PJ;
- Costello, JF
- Article
8
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 188, doi. 10.1111/j.1365-2125.1989.tb05415.x
- Dryjski, M.;
- Schneider, DE;
- Mojaverian, P.;
- Kuo, BS;
- Bjornsson, TD
- Article
9
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 155, doi. 10.1111/j.1365-2125.1989.tb05408.x
- Article
10
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 205, doi. 10.1111/j.1365-2125.1989.tb05419.x
- Hellgren, U.;
- Kihamia, CM;
- Premji, Z.;
- Danielson, K.
- Article
11
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 166, doi. 10.1111/j.1365-2125.1989.tb05410.x
- Back, DJ;
- Stevenson, P.;
- Tjia, JF
- Article
12
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 208, doi. 10.1111/j.1365-2125.1989.tb05421.x
- Article
13
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 185, doi. 10.1111/j.1365-2125.1989.tb05414.x
- Tan, KK;
- Trull, AK;
- Shawket, S.
- Article
14
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 151, doi. 10.1111/j.1365-2125.1989.tb05407.x
- te Koppele, JM;
- Schipper, C.;
- Breimer, DD;
- Mulder, GJ
- Article
15
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 202, doi. 10.1111/j.1365-2125.1989.tb05418.x
- Olkkola, KT;
- Maunuksela, EL;
- Korpela, R.
- Article
16
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 207, doi. 10.1111/j.1365-2125.1989.tb05420.x
- Lorenzo, B.;
- Reidenberg, MM
- Article
17
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 179, doi. 10.1111/j.1365-2125.1989.tb05413.x
- Franssen, G.;
- Rouveix, B.;
- Lebras, J.;
- Bauchet, J.;
- Verdier, F.;
- Michon, C.;
- Bricaire, F.
- Article
18
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 143, doi. 10.1111/j.1365-2125.1989.tb05406.x
- Evans, AM;
- Nation, RL;
- Sansom, LN
- Article
19
- British Journal of Clinical Pharmacology, 1989, v. 28, n. 2, p. 197, doi. 10.1111/j.1365-2125.1989.tb05417.x
- Salako, LA;
- Sowunmi, A.;
- Akinbami, FO
- Article